Anti-aging and Anti-oxidant Efficacy Evaluation of the MelaGene

TCI

Status

Completed

Conditions

Antioxidative Stress

Aging

Treatments

Dietary Supplement: Placebo drink

Dietary Supplement: MelaGene drink

Study type

Interventional

Funder types

Industry

Identifiers

TSMH IRB No. 21-057-A

Details and patient eligibility

About

The primary purpose of the present study is to evaluate the effects of MelaGene on anti-aging and anti-oxidant.

Enrollment

51 patients

Sex

All

Ages

30 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

30 to 65-year-old;
Must read and sign the informed consent form before the experiment;
People who are willing to cooperate with contraception during the trial period;
Do not change lifestyle and eating habits arbitrarily during the trial period;
Do not take supplementary foods and health supplements with the same efficacy two weeks before and during the test;
If any adverse reaction occurs during the experiment, subjects should be notified the researcher immediately.

Exclusion criteria

Subject who is not willing to participate in this study;
Vegetarians;
People with a history of organ transplantation, epilepsy or convulsions, liver and kidney disease, malignant tumors, endocrine diseases, mental illness, alcohol or drug abuse, and other major organic diseases (according to medical history);
Participate in other clinical trials related to antioxidants and anti-aging four weeks before and during the test;
People with a history of dyspepsia would affect the absorption of the test product;
Allergic to the components of the test product;
Pregnant or breast-feeding women;
Take anti-oxidant supplements;
Undergoing hormone replacement therapy.